Cure My Disease

Don't miss your cure!

 Log in / Sign up

Ultrasound may reveal the true staying power of facial fat grafts

NCT ID NCT07805889

Knowledge-focused Sponsor: Research Inc Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

Facelift surgery repositions facial tissues but does not restore all lost volume. Surgeons often add the patient's own fat during the same operation to fill out the face, yet how much of that fat remains after a year is not well measured. This study follows 400 adults aged 18 to 65 who are scheduled for a facelift with fat grafting. Researchers use ultrasound scans at one month and one year after surgery to measure how much grafted fat persists and how the facial tissue changes over time.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Facelift surgery combined with facial fat grafting using the patient's own fat (macrofat)
What this could lead to
If successful, this could help surgeons know which fat grafting techniques lead to longer-lasting results, improving outcomes for facelift patients.
What could go wrong
This is an observational study, not a test of a new treatment. It will not prove which technique is best, and results may vary due to individual healing and measurement differences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2023

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults undergoing elective facelift surgery for facial aging in whom autologous facial macrofat grafting is planned as part of the operative protocol.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 to 65 years. * Scheduled for elective facelift surgery with facial autologous macrofat grafting specified before enrollment. * Ability to undergo standardized facial ultrasound at baseline, postoperative month 1, and postoperative month 12. * Capacity to provide written informed consent and comply with follow-up visits. Exclusion Criteria: * Prior facial fat grafting within 24 months before enrollment. * Active facial infection, uncontrolled inflammatory skin disease, or open facial wound. * Known lipodystrophy or systemic disease expected to substantially alter facial fat distribution during follow-up. * Planned major weight-loss intervention or anticipated body-weight change greater than 10% during follow-up. * Pregnancy or breastfeeding at enrollment. * Inability to obtain technically adequate baseline ultrasound measurements in the predefined facial zones.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facelift surgery are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Patient Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Facelift surgery Fat grafting

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    1 site. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • NS Plastic surgery

    RECRUITING

    Barranquilla, Colombia

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.